Adicet Bio, Inc.
ACET
$0.8345
$0.00660.80%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -31.22M | -28.21M | -28.73M | -30.48M | -29.90M |
| Total Depreciation and Amortization | 1.66M | 1.68M | 1.62M | 1.59M | 1.60M |
| Total Amortization of Deferred Charges | 0.00 | 15.00K | 0.00 | 0.00 | 0.00 |
| Total Other Non-Cash Items | 2.87M | 2.82M | 3.21M | 7.30M | 6.80M |
| Change in Net Operating Assets | 58.00K | -1.70M | -206.00K | -420.00K | -1.92M |
| Cash from Operations | -26.63M | -25.40M | -24.10M | -22.01M | -23.42M |
| Capital Expenditure | -47.00K | -1.49M | -176.00K | -401.00K | -302.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 33.00M | -1.37M | -118.12M | -- | -- |
| Cash from Investing | 32.95M | -2.86M | -118.30M | -401.00K | -302.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 267.00K | -- | 96.32M | 0.00 | 204.00K |
| Repurchase of Common Stock | 0.00 | -104.00K | -- | -96.18M | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 267.00K | -104.00K | 96.32M | -96.18M | 204.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.59M | -28.36M | -46.08M | -118.59M | -23.52M |